首页> 外文期刊>Analytical chemistry >Duplex Microfluidic SERS Detection of Pathogen Antigens with Nanoyeast Single-Chain Variable Fragments
【24h】

Duplex Microfluidic SERS Detection of Pathogen Antigens with Nanoyeast Single-Chain Variable Fragments

机译:纳米酵母单链可变片段的双链微流控SERS检测病原体抗原。

获取原文
获取原文并翻译 | 示例
       

摘要

Quantitative and accurate detection of multiple biomarkers would allow for the rapid diagnosis and treatment of diseases induced by pathogens. Monoclonal antibodies are standard affinity reagents applied for biomarkers detection; however, their production is expensive and labor-intensive. Herein, we report on newly developed nanoyeast single-chain variable fragments (NYscFv) as an attractive alternative to monoclonal antibodies, which offers the unique advantage of a cost-effective production, stability in solution, and target-specificity. By combination of surface-enhanced Raman scattering (SERS) microspectroscopy using glass-coated, highly purified SERS nanoparticle clusters as labels, with a microfluidic device comprising multiple channels, a robust platform for the sensitive duplex detection of pathogen antigens has been developed. Highly sensitive detection for individual Entamoeba histolytica antigen EHI_115350 (limit of detection = 1 pg/mL, corresponding to 58.8 fM) and EHI_182030 (10 pg/mL, corresponding 453 fM) with high specificity has been achieved, employing the newly developed corresponding NYscFv as probe in combination with SERS microspectroscopy at a single laser excitation wavelength. Our first report on SERS-based immunoassays using the novel NYscFv affinity reagent demonstrates the flexibility of NYscFv fragments as viable alternatives to monoclonal antibodies in a range of bioassay platforms and paves the way for further applications.
机译:定量和准确地检测多种生物标志物可以快速诊断和治疗由病原体引起的疾病。单克隆抗体是用于生物标志物检测的标准亲和试剂;但是,它们的生产昂贵且劳动强度大。在本文中,我们报道了最新开发的纳米酵母单链可变片段(NYscFv)作为单克隆抗体的诱人替代品,它提供了具有成本效益的生产,溶液稳定性和靶标特异性的独特优势。通过使用玻璃涂层,高度纯化的SERS纳米粒子簇作为标记的表面增强拉曼散射(SERS)显微光谱与包含多个通道的微流控设备相结合,已开发出用于病原体抗原敏感双工检测的强大平台。使用新开发的相应NYscFv作为抗体,已实现了高特异性的高特异性检测单个溶组织变形杆菌抗原EHI_115350(检测限= 1 pg / mL,对应于58.8 fM)和EHI_182030(10 pg / mL,对应于453 fM)。探针与SERS显微技术在单个激光激发波长下结合使用。我们关于使用新型NYscFv亲和试剂进行的基于SERS免疫测定的第一份报告证明了NYscFv片段具有灵活性,可以在一系列生物测定平台中替代单克隆抗体,为进一步的应用铺平了道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号